Lindley A Barbee1,2, Christine M Khosropour3, Olusegun O Soge1,4, James P Hughes5, Micaela Haglund1, Winnie Yeung1, Matthew R Golden1,2,3. 1. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA. 2. Public Health- Seattle & King County, HIV/STD Program, Seattle, Washington, USA. 3. Department of Epidemiology, University of Washington, Seattle, Washington, USA. 4. Neisseria Reference Laboratory, Department of Global Health, University of Washington, Seattle, Washington, USA. 5. Department of Biostatistics, University of Washington, Seattle, Washington, USA.
Abstract
BACKGROUND: The duration of rectal gonococcal and chlamydial infection remains unknown. This basic epidemiologic parameter is needed to understand transmission dynamics. METHODS: We conducted a prospective, longitudinal, observational cohort study of 140 men who have sex with men (MSM) at risk of gonorrhea and chlamydia acquisition. For 48 weeks, enrolled men collected rectal swabs (Aptima multi-test kit) at home and responded to an electronic survey about sexual behavior and health conditions weekly. Swabs remained untested until participants completed the study. We used Kaplan-Meier estimates to determine the median duration of infection, censoring infections for treatment, loss to follow-up, and end-of-study. We used log-rank test to compare duration of infection by human immunodeficiency virus (HIV) status, history of infection with gonorrhea or chlamydia, and coinfection with the other pathogen. RESULTS: 140 enrolled MSM contributed 70.5 person-years of follow-up. Eighteen men had 20 incident rectal gonococcal infections, which persisted for 2-23 weeks; 30% were censored for treatment. The estimated median duration of rectal gonorrhea was 9 weeks (95% confidence interval [CI]: 3-12 weeks). Twenty-four men experienced 32 rectal chlamydial infections, persisting between 2 and 42 weeks; 60% were censored. The estimated duration of rectal chlamydia was 13 weeks (95% CI: 6 weeks-undefined). There were no differences in the duration of rectal gonorrhea or chlamydia by HIV status, history of chlamydia/gonorrhea, or coinfection. CONCLUSIONS: On average, rectal gonorrhea and chlamydial infections last 2-3 months, although some infections persisted for 6-11 months. Further understanding into predictors of persistence is needed.
BACKGROUND: The duration of rectal gonococcal and chlamydial infection remains unknown. This basic epidemiologic parameter is needed to understand transmission dynamics. METHODS: We conducted a prospective, longitudinal, observational cohort study of 140 men who have sex with men (MSM) at risk of gonorrhea and chlamydia acquisition. For 48 weeks, enrolled men collected rectal swabs (Aptima multi-test kit) at home and responded to an electronic survey about sexual behavior and health conditions weekly. Swabs remained untested until participants completed the study. We used Kaplan-Meier estimates to determine the median duration of infection, censoring infections for treatment, loss to follow-up, and end-of-study. We used log-rank test to compare duration of infection by human immunodeficiency virus (HIV) status, history of infection with gonorrhea or chlamydia, and coinfection with the other pathogen. RESULTS: 140 enrolled MSM contributed 70.5 person-years of follow-up. Eighteen men had 20 incident rectal gonococcal infections, which persisted for 2-23 weeks; 30% were censored for treatment. The estimated median duration of rectal gonorrhea was 9 weeks (95% confidence interval [CI]: 3-12 weeks). Twenty-four men experienced 32 rectal chlamydial infections, persisting between 2 and 42 weeks; 60% were censored. The estimated duration of rectal chlamydia was 13 weeks (95% CI: 6 weeks-undefined). There were no differences in the duration of rectal gonorrhea or chlamydia by HIV status, history of chlamydia/gonorrhea, or coinfection. CONCLUSIONS: On average, rectal gonorrhea and chlamydial infections last 2-3 months, although some infections persisted for 6-11 months. Further understanding into predictors of persistence is needed.
Authors: Natasha Lewis; Gail Dube; Christine Carter; Rachel Pitt; Sarah Alexander; Catherine A Ison; Jan Harding; Louise Brown; John Fryer; James Hodson; Jonathan Ross Journal: Sex Transm Infect Date: 2012-04-25 Impact factor: 3.519
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Lei Zhang; David G Regan; Eric P F Chow; Manoj Gambhir; Vincent Cornelisse; Andrew Grulich; Jason Ong; David A Lewis; Jane Hocking; Christopher K Fairley Journal: Sex Transm Dis Date: 2017-10 Impact factor: 2.830
Authors: F Jin; G P Prestage; L Mao; S C Kippax; C M Pell; B Donovan; P H Cunningham; D J Templeton; J M Kaldor; A E Grulich Journal: Sex Transm Infect Date: 2006-09-27 Impact factor: 3.519
Authors: Eric P F Chow; Shayne Camilleri; Christopher Ward; Sarah Huffam; Marcus Y Chen; Catriona S Bradshaw; Christopher K Fairley Journal: Sex Health Date: 2016-06 Impact factor: 2.706
Authors: Winston E Abara; Eloisa L Llata; Christina Schumacher; Juli Carlos-Henderson; Angela M Peralta; Dawn Huspeni; Roxanne P Kerani; Heather Elder; Kim Toevs; Preeti Pathela; Lenore Asbel; Trang Q Nguyen; Kyle T Bernstein; Elizabeth A Torrone; Robert D Kirkcaldy Journal: Sex Transm Dis Date: 2020-06 Impact factor: 2.830
Authors: Julia C Dombrowski; Michael R Wierzbicki; Lori M Newman; Jonathan A Powell; Ashley Miller; Dwyn Dithmer; Olusegun O Soge; Kenneth H Mayer Journal: Clin Infect Dis Date: 2021-09-07 Impact factor: 9.079
Authors: Lindley A Barbee; Christine M Khosropour; Olusegun O Soge; James P Hughes; Micaela Haglund; Winnie Yeung; Matthew R Golden Journal: Clin Infect Dis Date: 2022-05-03 Impact factor: 20.999
Authors: Christine M Khosropour; Olusegun O Soge; Matthew R Golden; James P Hughes; Lindley A Barbee Journal: Clin Infect Dis Date: 2022-09-14 Impact factor: 20.999
Authors: Nicole H T M Dukers-Muijrers; Ymke J Evers; Christian J P A Hoebe; Petra F G Wolffs; Henry J C de Vries; Bernice Hoenderboom; Marianne A B van der Sande; Janneke Heijne; Jeffrey D Klausner; Jane S Hocking; Jan van Bergen Journal: BMC Infect Dis Date: 2022-03-14 Impact factor: 3.090
Authors: Lindley A Barbee; Christine M Khosropour; Olusegun O Soge; James P Hughes; Micaela Haglund; Winnie Yeung; Matthew R Golden Journal: Clin Infect Dis Date: 2022-05-03 Impact factor: 20.999